You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Moodys
Mallinckrodt
AstraZeneca
Baxter

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

FUROSEMIDE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for furosemide and what is the scope of freedom to operate?

Furosemide is the generic ingredient in two branded drugs marketed by Abraxis Pharm, Accord Hlthcare, Am Regent, Amneal Pharms Co, Astrazeneca, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Igi Labs Inc, Intl Medication, Marsam Pharms Llc, Smith And Nephew, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wockhardt, Wyeth Ayerst, Sanofi Aventis Us, Hikma, Wockhardt Bio Ag, Ani Pharms Inc, Avet, Dava Pharms Inc, Ipca Labs Ltd, Kalapharm, Leading Pharma Llc, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Watson Labs Teva, and Us Pharm Holdings, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for furosemide. Forty-six suppliers are listed for this compound.

Drug Prices for FUROSEMIDE

See drug prices for FUROSEMIDE

Drug Sales Revenue Trends for FUROSEMIDE

See drug sales revenues for FUROSEMIDE

Recent Clinical Trials for FUROSEMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rediscovery Life SciencesPhase 2
Chiang Mai UniversityPhase 3
Otsuka Pharmaceutical VietnamN/A

See all FUROSEMIDE clinical trials

Pharmacology for FUROSEMIDE
Medical Subject Heading (MeSH) Categories for FUROSEMIDE

US Patents and Regulatory Information for FUROSEMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int FUROSEMIDE furosemide INJECTABLE;INJECTION 071439-001 Sep 14, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs FUROSEMIDE furosemide TABLET;ORAL 018369-001 May 14, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Gland Pharma Ltd FUROSEMIDE furosemide INJECTABLE;INJECTION 213902-001 Jul 1, 2020 AP RX No No   Start Trial   Start Trial   Start Trial
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Hospira FUROSEMIDE furosemide INJECTABLE;INJECTION 075241-001 May 28, 1999 AP RX No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare Corp FUROSEMIDE furosemide INJECTABLE;INJECTION 202747-001 Jan 27, 2014 AP RX No Yes   Start Trial   Start Trial   Start Trial
Prinston Inc FUROSEMIDE furosemide TABLET;ORAL 076796-002 Mar 26, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FUROSEMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-003 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Sanofi Aventis Us LASIX furosemide INJECTABLE;INJECTION 016363-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Sanofi Aventis Us LASIX furosemide SOLUTION;ORAL 017688-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKesson
Medtronic
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.